| D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism EA Bolan, B Kivell, V Jaligam, M Oz, LD Jayanthi, Y Han, N Sen, E Urizar, ... Molecular pharmacology 71 (5), 1222-1232, 2007 | 275 | 2007 |
| Kappa opioids and the modulation of pain B Kivell, TE Prisinzano Psychopharmacology 210, 109-119, 2010 | 161 | 2010 |
| Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors A Zapata, B Kivell, Y Han, JA Javitch, EA Bolan, D Kuraguntla, V Jaligam, ... Journal of biological chemistry 282 (49), 35842-35854, 2007 | 143 | 2007 |
| Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism B Kivell, Z Uzelac, S Sundaramurthy, J Rajamanickam, A Ewald, V Chefer, ... Neuropharmacology 86, 228-240, 2014 | 116 | 2014 |
| Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells P Stoitzner, LK Green, JY Jung, KM Price, H Atarea, B Kivell, F Ronchese Cancer Immunology, Immunotherapy 57, 1665-1673, 2008 | 115 | 2008 |
| Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues AP Riley, CE Groer, D Young, AW Ewald, BM Kivell, TE Prisinzano Journal of medicinal chemistry 57 (24), 10464-10475, 2014 | 114 | 2014 |
| Estimating cross-price elasticity of e-cigarettes using a simulated demand procedure RC Grace, BM Kivell, M Laugesen Nicotine & Tobacco Research 17 (5), 592-598, 2014 | 112 | 2014 |
| Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats AS Morani, B Kivell, TE Prisinzano, S Schenk Pharmacology Biochemistry and Behavior 94 (2), 244-249, 2009 | 91 | 2009 |
| Salvinorin A analogs and other kappa-opioid receptor compounds as treatments for cocaine abuse BM Kivell, AWM Ewald, TE Prisinzano Advances in pharmacology 69, 481-511, 2014 | 82 | 2014 |
| Pharmacology and anti‐addiction effects of the novel κ opioid receptor agonist M esyl S al B, a potent and long‐acting analogue of salvinorin A B Simonson, AS Morani, AWM Ewald, L Walker, N Kumar, D Simpson, ... British journal of pharmacology 172 (2), 515-531, 2015 | 75 | 2015 |
| mRNA and microRNA analysis reveals modulation of biochemical pathways related to addiction in the ventral tegmental area of methamphetamine self-administering rats PJ Bosch, MC Benton, D Macartney-Coxson, BM Kivell BMC neuroscience 16, 1-13, 2015 | 63 | 2015 |
| The kappa opioid receptor: a promising therapeutic target for multiple pathologies ML Dalefield, B Scouller, R Bibi, BM Kivell Frontiers in Pharmacology 13, 837671, 2022 | 59 | 2022 |
| Method for serum-free culture of late fetal and early postnatal rat brainstem neurons BM Kivell, FJ McDonald, JH Miller Brain Research Protocols 6 (3), 91-99, 2001 | 59 | 2001 |
| Serum-free culture of rat post-natal and fetal brainstem neurons BM Kivell, FJ McDonald, JH Miller Developmental Brain Research 120 (2), 199-210, 2000 | 59 | 2000 |
| Strategies for developing κ opioid receptor agonists for the treatment of pain with fewer side effects KF Paton, DV Atigari, S Kaska, T Prisinzano, BM Kivell Journal of Pharmacology and Experimental Therapeutics 375 (2), 332-348, 2020 | 54 | 2020 |
| Real‐time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+ M Oz, T Libby, B Kivell, V Jaligam, S Ramamoorthy, TS Shippenberg Journal of neurochemistry 114 (4), 1019-1029, 2010 | 52 | 2010 |
| Developmental expression of μ and δ opioid receptors in the rat brainstem: evidence for a postnatal switch in μ isoform expression BM Kivell, DJ Day, FJ McDonald, JH Miller Developmental brain research 148 (2), 185-196, 2004 | 52 | 2004 |
| The analgesic and anti‐inflammatory effects of Salvinorin A analogue β‐tetrahydropyran Salvinorin B in mice KF Paton, N Kumar, RS Crowley, JL Harper, TE Prisinzano, BM Kivell European Journal of Pain 21 (6), 1039-1050, 2017 | 51 | 2017 |
| Peloruside-and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII-and βIII-tubulin isotypes A Kanakkanthara, A Wilmes, A O'Brate, D Escuin, A Chan, A Gjyrezi, ... Molecular cancer therapeutics 10 (8), 1419-1429, 2011 | 51 | 2011 |
| Oxidative metabolism as a modulator of kratom’s biological actions S Chakraborty, R Uprety, ST Slocum, T Irie, V Le Rouzic, X Li, LL Wilson, ... Journal of medicinal chemistry 64 (22), 16553-16572, 2021 | 47 | 2021 |
Tom PrisinzanoUniversity of KentuckyBestätigte E-Mail-Adresse bei uky.edu